Claim construction opinion issues in venlafaxine litigation

Posted on January 6, 2008 by MorrisJames Delaware

Wyeth  v. Impax Laboratories, Inc., C.A. No.06-222-JJF, December 13, 2007.

Farnan, J.  Claim construction opinion.

The patents-in-suit relate to the drug venlafaxine (Wyeth’s Effexor XR) used for the treatment of depression and other disorders.  The Court largely adopts the patentee’s claim constructions.

A copy of the full opinion is available here.
Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://depatentlaw.morrisjames.com/admin/trackback/55151
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.